Found: 16
Select item for more details and to access through your institution.
Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-06614-9
- By:
- Publication type:
- Article
Implementing Personalized Medicine in COVID-19 in Andalusia: An Opportunity to Transform the Healthcare System.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 6, p. 475, doi. 10.3390/jpm11060475
- By:
- Publication type:
- Article
Impact of a Loss-of-Function Variant in HSD17B13 on Hepatic Decompensation and Mortality in Cirrhotic Patients.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 19, p. 11840, doi. 10.3390/ijms231911840
- By:
- Publication type:
- Article
High levels of histones promote whole- genome-duplications and trigger a Swe1<sup>WEE1</sup>-dependent phosphorylation of Cdc28<sup>CDK1</sup>.
- Published in:
- eLife, 2018, p. 1, doi. 10.7554/eLife.35337
- By:
- Publication type:
- Article
Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.667354
- By:
- Publication type:
- Article
A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy.
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 192, doi. 10.3390/cancers14010192
- By:
- Publication type:
- Article
Novel insights into metabolic‐associated steatotic liver disease preclinical models.
- Published in:
- Liver International, 2024, v. 44, n. 3, p. 644, doi. 10.1111/liv.15830
- By:
- Publication type:
- Article
Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD.
- Published in:
- Liver International, 2023, v. 43, n. 9, p. 1909, doi. 10.1111/liv.15604
- By:
- Publication type:
- Article
Long non‐coding RNA H19 as a biomarker for hepatocellular carcinoma.
- Published in:
- Liver International, 2022, v. 42, n. 6, p. 1410, doi. 10.1111/liv.15230
- By:
- Publication type:
- Article
Management of NAFLD patients with advanced fibrosis.
- Published in:
- Liver International, 2021, v. 41, p. 95, doi. 10.1111/liv.14847
- By:
- Publication type:
- Article
Detailed stratified GWAS analysis for severe COVID-19 in four European populations.
- Published in:
- Human Molecular Genetics, 2022, v. 31, n. 23, p. 3945, doi. 10.1093/hmg/ddac158
- By:
- Publication type:
- Article
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis.
- Published in:
- Journal of Gastroenterology, 2024, v. 59, n. 7, p. 586, doi. 10.1007/s00535-024-02098-8
- By:
- Publication type:
- Article
Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Contribution of Liver and Pancreatic Islet Crosstalk to β-Cell Function/Dysfunction in the Presence of Fatty Liver.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.892672
- By:
- Publication type:
- Article
Crosstalk between chromatin structure, cohesin activity and transcription.
- Published in:
- Epigenetics & Chromatin, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13072-019-0293-6
- By:
- Publication type:
- Article
Transcription and FACT facilitate the restoration of replication-coupled chromatin assembly defects.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-38280-w
- By:
- Publication type:
- Article